Black Swan Sale

50% Off Elite

Register Now!

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

Last Close
Nov 21  •  04:00PM ET
22.38
Dollar change
+1.22
Percentage change
5.77
%
Index- P/E39.34 EPS (ttm)0.57 Insider Own81.82% Shs Outstand49.71M Perf Week1.36%
Market Cap6.11B Forward P/E30.31 EPS next Y0.74 Insider Trans0.00% Shs Float49.60M Perf Month-18.94%
Enterprise Value6.50B PEG2.09 EPS next Q0.19 Inst Own19.18% Short Float5.04% Perf Quarter1.77%
Income155.28M P/S4.72 EPS this Y10.08% Inst Trans0.62% Short Ratio6.74 Perf Half Y0.31%
Sales1.29B P/B3.62 EPS next Y21.19% ROA5.85% Short Interest2.50M Perf YTD2.71%
Book/sh6.19 P/C45.86 EPS next 5Y18.84% ROE9.81% 52W High28.00 -20.07% Perf Year23.31%
Cash/sh0.49 P/FCF- EPS past 3/5Y-7.81% 23.16% ROIC7.32% 52W Low17.81 25.66% Perf 3Y55.09%
Dividend Est.0.05 (0.24%) EV/EBITDA21.85 Sales past 3/5Y6.18% 14.74% Gross Margin27.59% Volatility6.20% 5.93% Perf 5Y-
Dividend TTM0.06 (0.28%) EV/Sales5.02 EPS Y/Y TTM23.06% Oper. Margin15.84% ATR (14)1.36 Perf 10Y-
Dividend Ex-DateJun 05, 2025 Quick Ratio1.30 Sales Y/Y TTM9.19% Profit Margin11.99% RSI (14)41.40 Recom1.55
Dividend Gr. 3/5Y6.27% - Current Ratio1.89 EPS Q/Q27.71% SMA20-5.71% Beta0.63 Target Price28.74
Payout13.11% Debt/Eq0.31 Sales Q/Q16.06% SMA50-10.01% Rel Volume0.63 Prev Close21.16
Employees- LT Debt/Eq0.26 EarningsNov 06 BMO SMA200-3.70% Avg Volume370.75K Price22.38
IPOJul 16, 2021 Option/ShortYes / Yes EPS/Sales Surpr.9.16% 2.95% Trades Volume232,715 Change5.77%
Date Action Analyst Rating Change Price Target Change
Dec-13-24Initiated Wolfe Research Outperform $28
Dec-03-24Resumed Morgan Stanley Equal-Weight $23
Apr-22-24Initiated Exane BNP Paribas Outperform
Nov-01-23Downgrade Jefferies Buy → Hold $39 → $29
Sep-26-23Initiated Stephens Overweight $33
Sep-19-23Initiated CJS Securities Market Outperform
Aug-24-23Downgrade Morgan Stanley Overweight → Equal-Weight $34
Aug-10-21Initiated Wells Fargo Overweight $24
Aug-10-21Initiated Morgan Stanley Overweight $26
Aug-10-21Initiated KeyBanc Capital Markets Overweight $27
Nov-06-25 07:45AM
06:38AM
06:30AM
Oct-31-25 12:09PM
07:30AM
06:30AM Loading…
Oct-22-25 06:30AM
Oct-21-25 06:30AM
Oct-10-25 11:40AM
Oct-07-25 06:04AM
Sep-15-25 11:40AM
Sep-12-25 08:16AM
Sep-11-25 12:00PM
Sep-02-25 05:59PM
Aug-28-25 11:40AM
Aug-25-25 08:30AM
11:40AM Loading…
Aug-12-25 11:40AM
Aug-05-25 07:40AM
06:38AM
06:30AM
Jul-29-25 10:00AM
Jul-25-25 11:40AM
10:06AM
Jul-23-25 01:18PM
06:30AM
Jul-22-25 04:30PM
Jul-09-25 11:40AM
Jun-18-25 11:40AM
11:40AM
11:40AM
11:40AM
11:40AM Loading…
11:40AM
11:40AM
11:40AM
11:40AM
11:40AM
11:40AM
11:40AM
11:40AM
11:40AM
11:40AM
Jun-02-25 11:40AM
May-30-25 01:07AM
May-09-25 04:03PM
03:20AM
May-08-25 07:50AM
06:46AM
06:37AM
May-07-25 09:41AM
May-06-25 11:40AM
08:55AM
Apr-24-25 05:15PM
Mar-11-25 04:30PM
Mar-07-25 02:09AM
01:52AM
Mar-06-25 07:45AM
06:48AM
06:31AM
Mar-05-25 07:05AM
Feb-24-25 04:02PM
Feb-23-25 01:35PM
Feb-13-25 12:16AM
Jan-07-25 04:30PM
Dec-14-24 06:45AM
Dec-04-24 07:55AM
Nov-11-24 06:32AM
Nov-06-24 02:13AM
Nov-05-24 07:45AM
06:43AM
06:31AM
Nov-04-24 07:03AM
Oct-22-24 04:30PM
10:01AM
Oct-08-24 07:25AM
Oct-01-24 06:30AM
Sep-30-24 11:31AM
Sep-27-24 10:48AM
Sep-26-24 07:04AM
Sep-12-24 08:54AM
Sep-11-24 04:28AM
Aug-29-24 04:30PM
Aug-23-24 06:54AM
Aug-16-24 03:36AM
Aug-07-24 08:42AM
01:25AM
Aug-06-24 07:50AM
06:47AM
06:31AM
Jul-25-24 06:30AM
Jul-19-24 10:00AM
May-30-24 05:00AM
May-28-24 07:00AM
May-24-24 04:10PM
May-23-24 04:30PM
May-13-24 07:05AM
May-12-24 09:25AM
May-10-24 12:44AM
May-09-24 12:45PM
10:53AM
09:16AM
08:52AM
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stocchi MauroCHIEF BUSINESS OFFICERJun 12 '25Proposed Sale21.5612,888277,865Jun 11 09:43 AM